|
CA2185671A1
(en)
*
|
1994-03-15 |
1995-09-21 |
Prizm Pharmaceuticals, Inc. |
Heparin-binding growth factors for gene therapy and anterior eye disorders
|
|
CN1269805A
(zh)
|
1997-07-14 |
2000-10-11 |
博尔德生物技术公司 |
生长激素和相关蛋白的衍生物
|
|
US20080076706A1
(en)
|
1997-07-14 |
2008-03-27 |
Bolder Biotechnology, Inc. |
Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
|
|
US7153943B2
(en)
|
1997-07-14 |
2006-12-26 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins, and methods of use thereof
|
|
US7495087B2
(en)
|
1997-07-14 |
2009-02-24 |
Bolder Biotechnology, Inc. |
Cysteine muteins in the C-D loop of human interleukin-11
|
|
EP1054694A2
(en)
|
1998-02-13 |
2000-11-29 |
Selective Genetics, Inc. |
Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby
|
|
US7157418B1
(en)
|
1998-07-22 |
2007-01-02 |
Osprey Pharmaceuticals, Ltd. |
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
|
AU2405900A
(en)
*
|
1999-01-04 |
2000-07-24 |
University Of Vermont And State Agricultural College, The |
Methods and products for delivering nucleic acids
|
|
US6903077B1
(en)
|
1999-01-04 |
2005-06-07 |
University Of Vermont And State Agricultural College |
Methods and products for delivering nucleic acids
|
|
US8288126B2
(en)
|
1999-01-14 |
2012-10-16 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
JP2002534119A
(ja)
*
|
1999-01-14 |
2002-10-15 |
ボルダー バイオテクノロジー， インコーポレイテッド |
自由システイン残基を有するタンパク質の生産方法
|
|
MXPA01012500A
(es)
*
|
1999-06-03 |
2003-10-14 |
Bioinnovation Ltd |
Productos para terapia de gen.
|
|
US6506365B1
(en)
*
|
2000-09-25 |
2003-01-14 |
Baxter Aktiengesellschaft |
Fibrin/fibrinogen binding conjugate
|
|
JP2002161049A
(ja)
*
|
2000-11-28 |
2002-06-04 |
Terumo Corp |
血管内膜肥厚抑制剤
|
|
GB0209896D0
(en)
|
2002-04-30 |
2002-06-05 |
Molmed Spa |
Conjugate
|
|
US7270983B1
(en)
*
|
2004-02-19 |
2007-09-18 |
Research Foundation Of The University Of Central Florida, Inc. |
Messenger RNA profiling: body fluid identification using multiplex reverse transcription-polymerase chain reaction (RT-PCR)
|
|
PT2043662E
(pt)
*
|
2006-07-26 |
2015-11-25 |
Intrexon Corp |
Métodos e composições para tratamento de doença
|
|
CA2796459C
(en)
|
2010-04-16 |
2016-05-24 |
Salk Institute For Biological Studies |
Methods for treating metabolic disorders using fgf-1
|
|
WO2015061331A1
(en)
|
2013-10-21 |
2015-04-30 |
Salk Institute For Biological Studies |
Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use
|
|
WO2017127493A1
(en)
*
|
2016-01-22 |
2017-07-27 |
Salk Institute For Biological Studies |
Fgf2 truncations and mutants and uses thereof
|
|
KR20230043115A
(ko)
*
|
2020-06-24 |
2023-03-30 |
사프렘 테크놀로지스 비.브이. |
히드라존에 기반한 사포닌 유도체
|
|
IL299358A
(en)
*
|
2020-06-24 |
2023-02-01 |
Sapreme Tech Bv |
Medicinal preparations containing saponin derivatives
|
|
CH716377B1
(it)
*
|
2020-08-05 |
2020-12-30 |
Contrad Swiss Sa |
Idrogel ad applicazione topica efficace nel prevenire e/o attenuare la degenerazione della cartilagine.
|